Cargando…

Clinical significance of HRAS and KRAS genes expression in patients with non–small-cell lung cancer - preliminary findings

BACKGROUND: The RAS family protooncogenes, including KRAS, NRAS and HRAS, encode proteins responsible for the regulation of growth, differentiation and survival of many cell types. The HRAS and KRAS oncogene mutations are well defined, however, the clinical significance of RAS expressions in non–sma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pązik, Milena, Michalska, Katarzyna, Żebrowska-Nawrocka, Marta, Zawadzka, Izabela, Łochowski, Mariusz, Balcerczak, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866659/ https://www.ncbi.nlm.nih.gov/pubmed/33549031 http://dx.doi.org/10.1186/s12885-021-07858-w

Ejemplares similares

The impact of ABCB1 gene polymorphism and its expression on non-small-cell lung cancer development, progression and therapy – preliminary report
por: Zawadzka, Izabela, et al.
Publicado: (2020)

The Interaction between Four Polymorphisms and Haplotype of ABCB1, the Risk of Non-Small Cell Lung Cancer, and the Disease Phenotype
por: Jeleń, Agnieszka, et al.
Publicado: (2023)

The contribution of ABCG2 G34A and C421A polymorphisms to multiple myeloma susceptibility
por: Niebudek, Katarzyna, et al.
Publicado: (2019)

Effects of the SLCO1B1 A388G single nucleotide polymorphism on the development, clinical parameters, treatment, and survival of multiple myeloma cases in a Polish population
por: Michalska, Katarzyna, et al.
Publicado: (2022)

Correlation of TIMP1-MMP2/MMP9 Gene Expression Axis Changes with Treatment Efficacy and Survival of NSCLC Patients
por: Pietrzak, Jacek, et al.
Publicado: (2023)

Preliminary investigation of two promoter region polymorphisms of the TNFA gene in patients with recurrent depressive disorder
por: Jeleń, Agnieszka, et al.
Publicado: (2021)

HMGA1 gene expression level in cancer tissue and blood samples of non-small cell lung cancer (NSCLC) patients: preliminary report
por: Saed, Lias, et al.
Publicado: (2022)

Zinc Finger E-Box Binding Homeobox Family: Non-Coding RNA and Epigenetic Regulation in Gliomas
por: Lenda, Bartosz, et al.
Publicado: (2023)

Expression level of CEBPA gene in acute lymphoblastic leukemia individuals
por: Szmajda, Dagmara, et al.
Publicado: (2019)

The Prognostic Significance of Preoperative Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Patients Operated for Non-Small Cell Lung Cancer
por: Łochowski, Mariusz, et al.
Publicado: (2021)

ABCG2 in peptic ulcer: gene expression and mutation analysis
por: Salagacka-Kubiak, Aleksandra, et al.
Publicado: (2015)

Association between the CEBPA and c-MYC genes expression levels and acute myeloid leukemia pathogenesis and development
por: Krygier, Adrian, et al.
Publicado: (2020)

RUNX1 and RUNX3 Genes Expression Level in Adult Acute Lymphoblastic Leukemia—A Case Control Study
por: Szmajda-Krygier, Dagmara, et al.
Publicado: (2022)

The Influence of C3435T Polymorphism of the ABCB1 Gene on Genetic Susceptibility to Depression and Treatment Response in Polish Population - Preliminary Report
por: Jeleń, Agnieszka Maria, et al.
Publicado: (2015)

Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck
por: Sasaki, Eiichi, et al.
Publicado: (2020)

Influence of Block of NF-Kappa B Signaling Pathway on Oxidative Stress in the Liver Homogenates
por: Kleniewska, Paulina, et al.
Publicado: (2013)

Prognostic Factors Determining Survival of Patients Operated for Non-Small Cell Lung Cancer with Consideration Given to Morphological Parameters of Blood
por: Łochowski, Mariusz, et al.
Publicado: (2021)

Functional characterisation of a novel class of in-frame insertion variants of KRAS and HRAS
por: Eijkelenboom, Astrid, et al.
Publicado: (2019)

Assessment of the Role of Selected SMAD3 and SMAD4 Genes Polymorphisms in the Development of Colorectal Cancer: Preliminary Research
por: Wosiak, Agnieszka, et al.
Publicado: (2021)

Differential Expression of AP-2 Transcription Factors Family in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma—A Bioinformatics Study
por: Szmajda-Krygier, Dagmara, et al.
Publicado: (2023)

Reversible intracellular translocation of KRas but not HRas in hippocampal neurons regulated by Ca(2+)/calmodulin
por: Fivaz, Marc, et al.
Publicado: (2005)

Prognostic value of selected platelet parameters of patients operated for non-small cell lung cancer
por: Łochowski, Mariusz, et al.
Publicado: (2022)

Prognostic value of red blood cell distribution width-standard deviation (RDW-SD) in patients operated on due to non-small cell lung cancer
por: Łochowski, Mariusz, et al.
Publicado: (2020)

Importance of Altered Gene Expression of Metalloproteinases 2, 9, and 16 in Acute Myeloid Leukemia: Preliminary Study
por: Pietrzak, Jacek, et al.
Publicado: (2021)

Whole exome sequencing reveals somatic mutations in HRAS and KRAS which cause nevus sebaceus
por: Levinsohn, Jonathan L., et al.
Publicado: (2012)

Early and Late Induction of KRAS and HRAS Proto-Oncogenes by Reactive Oxygen Species in Primary Astrocytes
por: Messina, Samantha, et al.
Publicado: (2017)

Reduced HRAS(G12V)-Driven Tumorigenesis of Cell Lines Expressing KRAS(C118S)
por: Huang, Lu, et al.
Publicado: (2015)

Investigation of -308G>A and -1031T>C Polymorphisms in the TNFA Promoter Region in Polish Peptic Ulcer Patients
por: Sałagacka, Aleksandra, et al.
Publicado: (2014)

BQ123 Stimulates Skeletal Muscle Antioxidant Defense via Nrf2 Activation in LPS-Treated Rats
por: Kowalczyk, Agata, et al.
Publicado: (2016)

FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
por: Kompier, Lucie C., et al.
Publicado: (2010)

Elderly Former Smoker with HRAS Mutant Non–Small-Cell Lung Cancer
por: Cathcart-Rake, Elizabeth, et al.
Publicado: (2014)

Prognostic significance of KRAS gene mutations in colorectal cancer - preliminary study
por: Dinu, D, et al.
Publicado: (2014)

Breast Cancer Heterogeneity Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal Carcinomas()()
por: Myers, Meagan B., et al.
Publicado: (2016)

Mechanism of the Exchange Reaction in HRAS from Multiscale Modeling
por: Kapoor, Abhijeet, et al.
Publicado: (2014)

HRAS mutation prevalence and associated expression patterns in pheochromocytoma
por: Stenman, Adam, et al.
Publicado: (2016)

Phacomatosis pigmentokeratotica and precocious puberty associated with HRAS mutation
por: Martin, R.J., et al.
Publicado: (2017)

Profile of BRAFV600E, BRAFK601E, NRAS, HRAS, and KRAS Mutational Status, and Clinicopathological Characteristics of Papillary Thyroid Carcinoma in Indonesian National Referral Hospital
por: Harahap, Agnes Stephanie, et al.
Publicado: (2023)

Mutant HRAS as novel target for MEK and mTOR inhibitors
por: Kiessling, Michael K., et al.
Publicado: (2015)

MTH1 expression is required for effective transformation by oncogenic HRAS
por: Giribaldi, Maria G., et al.
Publicado: (2015)

The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma
por: Wan, Xiaohua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c7g0fbd8qnessuvre005s2re7o